1,25-dihydroxyergocalciferol has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellingsen, T; Herly, M; Hetland, ML; Hørslev-Petersen, K; Junker, P; Stengaard-Pedersen, K; Vestergaard, P; Østergaard, M | 1 |
| Appel, LJ; Araneta, MR; Barrett-Connor, E; Michos, ED; Miller, ER; Reis, JP; von Mühlen, D | 1 |
1 trial(s) available for 1,25-dihydroxyergocalciferol and Disease Exacerbation
| Article | Year |
|---|---|
The D-vitamin metabolite 1,25(OH)
Topics: Adult; Aged; Anti-Citrullinated Protein Antibodies; Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Calcitriol; Disease Progression; Ergocalciferols; Female; Humans; Immunity, Humoral; Male; Middle Aged; Severity of Illness Index; Vitamin D; Young Adult | 2018 |
1 other study(ies) available for 1,25-dihydroxyergocalciferol and Disease Exacerbation
| Article | Year |
|---|---|
Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis.
Topics: Aged; Aged, 80 and over; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Cross-Sectional Studies; Disease Progression; Ergocalciferols; Female; Humans; Male; Middle Aged; Parathyroid Hormone; Risk Assessment; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography; Vitamin D | 2009 |